Our press documents

You are a journalist and you would like to receive our press releases by e-mail? Please, ask to presse@pasteur.fr

Filter press documents

Une étude préclinique montre que l’hydroxychloroquine n’a pas d’effet antiviral contre le SARS-CoV-2 in vivo
Press release
A study on the effects of hydroxychloroquine n macaques infected with the SARS-CoV-2 virus, used alone or in...
Press release
Teams from Strasbourg University Hospital and the Institut Pasteur carried out a study among hospital staff on the two...
Candidat vaccin MV-SARS-CoV-2 : un nouveau partenariat entre l’Institut Pasteur, la CEPI, Thémis et MSD
Press release
Institut Pasteur announces recent advances in the development of one of its candidate vaccines, MV-SARS-CoV-2, using...
VIH : une fenêtre de vulnérabilité pour le renouvellement du réservoir viral après allogreffe de cellules souches
Press release
Current HIV treatments efficiently block viral multiplication but cannot cure infection as they do not target HIV...
Press release
An international effort including researchers from University of California San Francisco (UCSF), Gladstone Institutes...
Press Info
Following the emergence of COVID-19 disease in Wuhan in December 2019, syndromic surveillance was implemented in France...
Press release
Approximately four months after the initial description of cases of atypical pneumonia in Wuhan, China, in December...
Press release
The SARS-CoV-2 global pandemic has resulted in extreme measures, with several countries imposing a lockdown on their...
Press release
The Bill & Melinda Gates Medical Research Institute (Gates MRI) and the Institut Pasteur have entered into an...



Subscribe to our newsletter

Back to top